✦ LIBER ✦

Cellular Immunity to Epstein-Barr Virus in Liver Transplant Recipients Treated with Rituximab for Post-Transplant Lymphoproliferative Disease

✍ Scribed by Barbara Savoldo; Cliona M. Rooney; Ruben E. Quiros-Tejeira; Yvette Caldwell; Hans-Joachim Wagner; Timothy Lee; Milton J. Finegold; Gianpietro Dotti; Helen E. Heslop; John A. Goss

Book ID: 114803325
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 140 KB
Volume: 5
Category: Article
ISSN: 1600-6135
DOI: 10.1111/j.1600-6143.2004.00693.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prolonged hypogammaglobulinemia followin

Prolonged hypogammaglobulinemia following rituximab treatment for post transplant Epstein–Barr virus-associated lymphoproliferative disease

✍ Imashuku, S; Teramura, T; Morimoto, A; Naya, M; Kuroda, H 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 104 KB

Factors associated with the development

Factors associated with the development of post-transplant lymphoproliferative disease (PTLD) in Epstein-Barr virus (EBV) - seronegative adult liver transplant recipients

✍ Rafael Mañez; Mary K. Breinig; Peter Linden; Shimon Kusne; Julian Torre-Cisneros 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 192 KB

Epstein-Barr virus-associated post-trans

Epstein-Barr virus-associated post-transplant lympho-proliferative disease of donor origin in liver transplant recipients

✍ Mario Strazzabosco; Barbara Corneo; Rosa Maria Iemmolo; Chiara Menin; Giorgio Ge 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 834 KB

Epstein–Barr Virus Polymerase Chain Reac

Epstein–Barr Virus Polymerase Chain Reaction–negative Stage IV Post-transplant Lymphoproliferative Disorder in a Heart Transplant Patient Treated With Rituximab

✍ Patrick Garceau; Christian Couture; Bernard Cantin; Vincent Bernier; Mario Sénéc 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 737 KB

Graft rejection in pediatric liver trans

Graft rejection in pediatric liver transplant patients with Epstein-Barr viremia and post-transplant lymphoproliferative disease

✍ Chana Weiner; Lauren Weintraub; Birte Wistinghausen; Juli Tomaino; Ronen Arnon; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB

Quantitative Epstein-Barr virus (EBV) se

Quantitative Epstein-Barr virus (EBV) serology in lung transplant recipients with primary EBV infection and/or post-transplant lymphoproliferative disease

✍ Erik Verschuuren; Wim van der Bij; Wim de Boer; Wim Timens; Jaap Middeldorp; T. 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB 👁 1 views

## Abstract The Epstein‐Barr virus (EBV)‐specific antibody response was studied in lung transplant patients to assess their value in the diagnosis and prognosis of post‐transplant lymphoproliferative disease. Recently developed synthetic peptides representing Epstein‐Barr nuclear antigen‐1 (EBNA‐1)